Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Pharmacy / 藥學專業學院
  4. Pharmacy / 藥學系
  5. Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells
 
  • Details

Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells

Journal
Molecular Pharmaceutics
Journal Volume
11
Journal Issue
8
Pages
2777-2786
Date Issued
2014
Author(s)
LI-JIUAN SHEN  
Wu, Fe-Lin Lin  
FE-LIN LIN WU  
Yeh, Tzyy-Harn
Chen, Ying-Luen
Chiu, Yu-Chin
Cheng, Ju-Chen
Wei, Ming-Feng
Shen, Li-Jiuan  
DOI
10.1021/mp5001372
URI
http://www.scopus.com/inward/record.url?eid=2-s2.0-84905459957&partnerID=MN8TOARS
http://scholars.lib.ntu.edu.tw/handle/123456789/383363
Abstract
Recombinant arginine deiminase (rADI) has been used in clinical trials for arginine-auxotrophic cancers. However, the emergence of rADI resistance, due to the overexpression of argininosuccinate synthetase (AS), has introduced an obstacle in its clinical application. Here, we have proposed a strategy for the intracellular delivery of rADI, which depletes both extracellular and intracellular arginine, to restore the sensitivity of rADI-resistant cancer cells. In this study, the C terminus of heparin-binding hemagglutinin adhesion protein from Mycobacterium tuberculosis (HBHAc), which contains 23 amino acids, was used to deliver rADI into rADI-resistant human breast adenocarcinoma cells (MCF-7). Chemical conjugates (l- and d-HBHAc-SPDP-rADI) and a recombinant fusion protein (rHBHAc-ADI) were produced. l- and d-HBHAc-SPDP-rADI showed a significantly higher cellular uptake of rADI by MCF-7 cells compared to that of rADI alone. Cell viability was significantly decreased in a dose-dependent manner in response to l- and d-HBHAc-SPDP-rADI treatments. In addition, the ratio of intracellular concentration of citrulline to arginine in cells treated with l- and d-HBHAc-SPDP-rADI was significantly increased by 1.4- and 1.7-fold, respectively, compared with that obtained in cells treated with rADI alone (p < 0.001). Similar results were obtained with the recombinant fusion protein rHBHAc-ADI. Our study demonstrates that the increased cellular uptake of rADI by HBHAc modification can restore the sensitivity of rADI treatment in MCF-7 cells. rHBHAc-ADI may represent a novel class of antitumor enzyme with an intracellular mechanism that is independent of AS expression. ? 2014 American Chemical Society.
Subjects
cancer; HBHA; heparin-binding hemagglutinin adhesion; intracellular delivery; rADI; recombinant arginine deiminase; resistance
SDGs

[SDGs]SDG3

Other Subjects
amino acid; arginine; arginine deiminase; citrulline; hemagglutinin; heparin binding hemagglutinin adhesion peptide; heparin binding protein; hybrid protein; unclassified drug; arginine deiminase; argininosuccinate synthase; citrulline; fluorescein; heparin-binding hemagglutinin; hybrid protein; hydrolase; lectin; peptide; article; breast adenocarcinoma; cancer cell; cancer resistance; cell viability; concentration (parameters); conjugate; controlled study; human; human cell; MCF 7 cell line; Mycobacterium tuberculosis; priority journal; synthesis; cell survival; chemistry; cytoplasm; dose response; drug delivery system; drug effects; drug resistance; endocytosis; metabolism; Neoplasms; tumor cell line; Amino Acids; Argininosuccinate Synthase; Cell Line, Tumor; Cell Survival; Citrulline; Cytoplasm; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Fluorescein; Humans; Hydrolases; Lectins; MCF-7 Cells; Mycobacterium tuberculosis; Neoplasms; Peptides; Recombinant Fusion Proteins
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science